HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raija H Tammi Selected Research

Hyaluronan Synthases

1/2019Activated hyaluronan metabolism in the tumor matrix - Causes and consequences.
8/2013Hyaluronan production enhances shedding of plasma membrane-derived microvesicles.
9/2010Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.
7/20094-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
5/2009Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
4/2008All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raija H Tammi Research Topics

Disease

10Neoplasms (Cancer)
01/2019 - 11/2003
6Inflammation (Inflammations)
01/2019 - 11/2007
3Wounds and Injuries (Trauma)
01/2017 - 02/2012
3Hyperplasia
10/2011 - 04/2008
2Endometrial Neoplasms (Endometrial Cancer)
04/2015 - 09/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2009 - 08/2008
2Melanoma (Melanoma, Malignant)
07/2009 - 08/2008
1Colonic Neoplasms (Colon Cancer)
08/2014
1Colorectal Neoplasms (Colorectal Cancer)
08/2014
1Cysts
08/2013
1Carcinogenesis
02/2012
1Erythema
10/2011
1Endometrioid Carcinoma
09/2010
1Ovarian Neoplasms (Ovarian Cancer)
05/2009
1Carcinoma (Carcinomatosis)
05/2009
1Starvation
09/2005
1Ovarian Epithelial Carcinoma
11/2003
1Residual Neoplasm
11/2003

Drug/Important Bio-Agent (IBA)

17Hyaluronic Acid (Hyaluronan)IBA
01/2019 - 11/2003
6Hyaluronan SynthasesIBA
01/2019 - 04/2008
4Messenger RNA (mRNA)IBA
04/2015 - 05/2009
3EnzymesIBA
01/2019 - 08/2014
3Uridine Diphosphate (UDP)IBA
01/2019 - 07/2009
3Proteins (Proteins, Gene)FDA Link
04/2015 - 05/2009
2Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
04/2015 - 05/2009
2Polysaccharides (Glycans)IBA
10/2011 - 05/2009
2Uridine Diphosphate Glucuronic Acid (UDP Glucuronic Acid)IBA
07/2009 - 09/2005
1SugarsIBA
01/2019
1Free RadicalsIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Uridine Triphosphate (UTP)IBA
01/2017
1HexosaminesIBA
01/2016
1SurvivinIBA
08/2014
1isothiocyanic acidIBA
08/2014
1IsothiocyanatesIBA
08/2014
1Interleukin-8 (Interleukin 8)IBA
06/2014
1CytokinesIBA
03/2013
1Mannose (D-Mannose)IBA
03/2013
1Hyaluronan ReceptorsIBA
10/2011
1ParaffinIBA
09/2010
1HymecromoneIBA
07/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2008
1U 0126 (UO 126)IBA
04/2008
1N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA
04/2008
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2008
1Matrix Metalloproteinases (MMPs)IBA
04/2008
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2008
1RTKI cpdIBA
04/2008

Therapy/Procedure

1Adjuvant Chemotherapy
11/2003